Login to Your Account



Financings Roundup

Endocyte, BG Slash IPO Prices But Shares Trade Up on Debut

By Jennifer Boggs


Monday, February 7, 2011
A day after Pacira Pharmaceuticals Inc. priced its $42 million initial public offering (IPO), two more life sciences companies followed: Oncology firm Endocyte Inc. priced 12.5 million shares at $6 each to raise $75 million while diagnostics company BG Medicine Inc. set a $7 price for 5 million shares to bring in $35 million. (See BioWorld Today, Feb. 4, 2011.)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription